Galectin Therapeutics Inc
GALT
Revenue
0.00
0.000.00%
-Assets
27.66M
▲1.77M▲6.82%
3 Months ChangeLiabilities
109.80M
▲12.83M▲13.23%
3 Months ChangeFree Cash Flow
-4.02M
▼-1.20M▼-42.31%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-09
Form 8-K
ID: 0001140361-24-040509
2024-08-13
Form 8-K
ID: 0001140361-24-036938
2024-08-13
Form 10-Q
ID: 0001140361-24-036937
2024-08-01
Form 8-K
ID: 0001140361-24-035212
2024-05-15
Form 8-K
ID: 0001140361-24-026106
2024-05-15
Form 10-Q
ID: 0001140361-24-026105
2024-03-29
Form 8-K
ID: 0001140361-24-016454
2023-12-11
Form 8-K
ID: 0001140361-23-057155
2023-12-07
Form 8-K
ID: 0001140361-23-056586
2023-11-13
Form 8-K
ID: 0001140361-23-052731